Michael Barbella, Managing Editor03.30.24
Partnerships and new product offerings drove ODT website traffic this past week.
Leading the way was Stryker's release of its Gamma4 hip fracture nailing system in most European markets. The Gamma4 system was engineered to treat hip and femur fractures, as well as streamline procedural workflows for surgeons. The system earned a CE mark in September 2023 and has been used in more than 25,000 cases in North America and Japan. It’s indicated to treat fractures in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur (including osteoporotic and osteopenic bone).
Other new product news—which transpired as a result of a partnership—came from MIMEDX Group, which forged an agreement with TELA Bio Inc. for exclusive rights to its manufacturing and supply agreement with Regenity Biosciences that will allow the company to add xenograft products to its Advanced Wound Care and Surgical solutions portfolio.
Smith+Nephew and Pathkeeper Surgical amassed pageviews for their respective collaborative moves this week. The former garnered interest for being named the Preferred Sports Medicine Technology Partner for mixed martial arts organization UFC. Under the partnership’s terms, Smith+Nephew said it will activate its brand to promote through the UFC’s huge worldwide presence to promote repair, regeneration, and recovery of Sports Medicine injuries through its advanced technologies.
Pathkeeper Surgical, meanwhile, followes suit with news that it has joined forces with the Mayo Clinic to research radiation levels in pediatric spine surgeries. The research will focus on reducing patient radiation exposure using minimally invasive optical navigation and utilizing intraoperative measurement tools for scoliosis correction, including vertebral body tethering.
Leading the way was Stryker's release of its Gamma4 hip fracture nailing system in most European markets. The Gamma4 system was engineered to treat hip and femur fractures, as well as streamline procedural workflows for surgeons. The system earned a CE mark in September 2023 and has been used in more than 25,000 cases in North America and Japan. It’s indicated to treat fractures in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur (including osteoporotic and osteopenic bone).
Other new product news—which transpired as a result of a partnership—came from MIMEDX Group, which forged an agreement with TELA Bio Inc. for exclusive rights to its manufacturing and supply agreement with Regenity Biosciences that will allow the company to add xenograft products to its Advanced Wound Care and Surgical solutions portfolio.
Smith+Nephew and Pathkeeper Surgical amassed pageviews for their respective collaborative moves this week. The former garnered interest for being named the Preferred Sports Medicine Technology Partner for mixed martial arts organization UFC. Under the partnership’s terms, Smith+Nephew said it will activate its brand to promote through the UFC’s huge worldwide presence to promote repair, regeneration, and recovery of Sports Medicine injuries through its advanced technologies.
Pathkeeper Surgical, meanwhile, followes suit with news that it has joined forces with the Mayo Clinic to research radiation levels in pediatric spine surgeries. The research will focus on reducing patient radiation exposure using minimally invasive optical navigation and utilizing intraoperative measurement tools for scoliosis correction, including vertebral body tethering.